TCL Archive In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.” July 29, 2005
TCL Archive Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin October 17, 2014
TCL Archive HCRA Response On DRGs and Clinical Research Threat Called A “Stone Wall,” Legislative Remedy Sought July 27, 1984